Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

NCT03969953 is registered in ClinicalTrials.gov with The George Institute as lead sponsor.

NCT NCT03969953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03969953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
Lead sponsor
The George Institute
Phase
Phase 3
Overall status
Completed
Start date
January 18, 2021
Completion date
October 30, 2025
Enrollment
1,753 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, chronic kidney diseases, dialysis-dependent kidney failure